Skip to main content
Have a personal or library account? Click to login
Predicting co-morbidities in chemically sensitive individuals from exhaled breath analysis Cover

Predicting co-morbidities in chemically sensitive individuals from exhaled breath analysis

Open Access
|Jan 2013

References

  1. Buters JT, Schober W, Gutermuth J, Jacob T, Aguilar-Pimentel A, Haus-Marp J,(2007). Toxicity of parked motor vehicle indoor air.(7): 2622-29.
  2. Corradi M, Gergelova P, Mutti A. (2010). Exhaled volatile organic compounds in nonrespiratory diseases.: 140-151.
  3. Goldstein JA, Faletto MB. (1993). Advances in Mechanisms of Activation and Deactivation of Environmental Chemicals.: 169-176.
  4. Jandacek RJ, Tso P. (2001). Factors af ecting the storage and excretion of toxic lipophilic xenobiotics.(12): 1289 -13 05.
  5. Jarnberg J, Johanson G, Lof A, Srahlbom B. (1998). Toxicokinetics of 1,2,4-tri-methylbenzene in humans exposed to vapours of white spirit: comparison with exposure to 1,2,4-trimethylbenzene alone.(8): 483-91.
  6. Kristiansen U, Nielsen GD. (1988). Activation of the sensory irritant receptor by C7-C11 n-alkanes.(6): 419-25.
  7. Laseter JL, Deleon IR, Rea WJ, Butler JR. (1983). Chlorinated hydrocarbon pesticides in environmentally sensitive patients.: 3-12.
  8. Monosson E. (2010). Biotransformation. The Encyclopedia of Earth. www. eoearth.org/article/biotransformation?topic=58074.
  9. Pan Y, Johnson AR, Rea WJ. (1991). Aliphatic hydrocarbon solvents in chemically sensitive patients.(7): 316-20.
  10. Pauling L, Robinson AB, Teranishi R, Cary P. (1971). Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography.: 2374-76.
  11. Perbellini L, Brugnon F, Caretta D, Maranelli G. (1985). Partition Coef cients of Some Industrial Aliphatic Hydrocarbons (C5-C7) in Blood and Human Tissues.: 162-67.
  12. Phillips M. (1997). Methods for the collection and assay of volatile organic compounds in breath.: 72-278.
  13. Phillips M, Cataneo RN, Cummin A. (2003a). Detection of lung cancer with volatile markers in the breath.: 2115-23.
  14. Phillips M, Cataneo RN, Ditkof BA. (2003b). Volatile markers of breast cancer in the breath.: 184-191.
  15. Phillips M, Cataneo RN, Cheema T. (2004a). Increased breath biomarkers of oxidative stress in diabetes mellitus.: 189-194.
  16. Phillips M, Boehmer J, Cataneo RN. (2004b). Prediction of heart transplant rejection with a breath test for markers of oxidative stress.: 1593 -19 5 4 .
  17. Rea WJ, Pan Y, Laseter JL. (1987). Toxic Volatile Organic Hydrocarbons in Chemically Sensitive Patients.(2): 70-74.
  18. Rea WJ. (1997).. Lewis Publishers, Boca Raton, FL.
  19. Silbergeld EK. (2011). Chapter 33. Toxicology, Part IV - Tools and Approaches. Workplace Health and Safety Information Home Page. Ilocis.org/docu-ments/chpt33e.htm. (Accessed May 14, 2011).
  20. Stadler JC, O'Neill AJ, Elliott GS, Kennedy G Jr. (2001). Repeated exposure inhalation study of pentane in rats.(2): 75-86.
  21. Zeliger HI. (2003). Toxic ef ects of chemical mixtures.(1): 23 -29.
  22. Zeliger HI. (2008).. William Andrew, Norwich, NY.
  23. Zeliger HI. (2011).Elsevier, London.
DOI: https://doi.org/10.2478/v10102-012-0020-7 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 123 - 126
Published on: Jan 16, 2013
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services

© 2013 Harold I. Zeliger, Yaqin Pan, William J. Rea, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.